These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 8664544)

  • 21. Peroxisome proliferator-activated receptors: a nuclear hormone receptor involved in adipocyte differentiation and lipid homeostasis.
    Shalev A; Meier CA
    Eur J Endocrinol; 1996 May; 134(5):541-2. PubMed ID: 8664970
    [No Abstract]   [Full Text] [Related]  

  • 22. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells.
    Nanbu-Wakao R; Fujitani Y; Masuho Y; Muramatu M; Wakao H
    Mol Endocrinol; 2000 Feb; 14(2):307-16. PubMed ID: 10674402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The farnesoid X receptor promotes adipocyte differentiation and regulates adipose cell function in vivo.
    Rizzo G; Disante M; Mencarelli A; Renga B; Gioiello A; Pellicciari R; Fiorucci S
    Mol Pharmacol; 2006 Oct; 70(4):1164-73. PubMed ID: 16778009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fad24, a mammalian homolog of Noc3p, is a positive regulator in adipocyte differentiation.
    Tominaga K; Johmura Y; Nishizuka M; Imagawa M
    J Cell Sci; 2004 Dec; 117(Pt 25):6217-26. PubMed ID: 15564382
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of PPAR gamma gene expression by nutrition and obesity in rodents.
    Vidal-Puig A; Jimenez-Liñan M; Lowell BB; Hamann A; Hu E; Spiegelman B; Flier JS; Moller DE
    J Clin Invest; 1996 Jun; 97(11):2553-61. PubMed ID: 8647948
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The roles of PPARs in adipocyte differentiation.
    Grimaldi PA
    Prog Lipid Res; 2001 Jul; 40(4):269-81. PubMed ID: 11412892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peroxisome proliferator-activated receptor gene expression in human tissues. Effects of obesity, weight loss, and regulation by insulin and glucocorticoids.
    Vidal-Puig AJ; Considine RV; Jimenez-Liñan M; Werman A; Pories WJ; Caro JF; Flier JS
    J Clin Invest; 1997 May; 99(10):2416-22. PubMed ID: 9153284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Expression of adipogenesis markers in a murine stromal cell line treated with 15-deoxy Delta(12,14)-prostaglandin J2, interleukin-11, 9-cis retinoic acid and vitamin K2.
    Garcia Palacios V; Morita I; Murota S
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):215-21. PubMed ID: 11728175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential activation of adipogenesis by multiple PPAR isoforms.
    Brun RP; Tontonoz P; Forman BM; Ellis R; Chen J; Evans RM; Spiegelman BM
    Genes Dev; 1996 Apr; 10(8):974-84. PubMed ID: 8608944
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differentiation of NIH3T3 fibroblasts into adipocytes induced by peroxisome proliferator activated receptor gamma 2 expression.
    Zuo X; Li G; Luo T; Li J; Liu Y; Luo M
    Chin Med J (Engl); 2001 Sep; 114(9):916-20. PubMed ID: 11780381
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Essential role of insulin-like growth factor I receptor in insulin-induced fetal brown adipocyte differentiation.
    Mur C; Arribas M; Benito M; Valverde AM
    Endocrinology; 2003 Feb; 144(2):581-93. PubMed ID: 12538620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. PPARgamma: an essential regulator of adipogenesis and modulator of fat cell function.
    Lowell BB
    Cell; 1999 Oct; 99(3):239-42. PubMed ID: 10555139
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential regulation of peroxisome proliferator activated receptor gamma1 (PPARgamma1) and PPARgamma2 messenger RNA expression in the early stages of adipogenesis.
    Saladin R; Fajas L; Dana S; Halvorsen YD; Auwerx J; Briggs M
    Cell Growth Differ; 1999 Jan; 10(1):43-8. PubMed ID: 9950217
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impaired lipid accumulation by trans10, cis12 CLA during adipocyte differentiation is dependent on timing and length of treatment.
    Granlund L; Pedersen JI; Nebb HI
    Biochim Biophys Acta; 2005 Feb; 1687(1-3):11-22. PubMed ID: 15708349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulating the transcriptional control of adipogenesis.
    Loftus TM; Lane MD
    Curr Opin Genet Dev; 1997 Oct; 7(5):603-8. PubMed ID: 9388775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. TNF-alpha inhibits 3T3-L1 adipocyte differentiation without downregulating the expression of C/EBPbeta and delta.
    Kurebayashi S; Sumitani S; Kasayama S; Jetten AM; Hirose T
    Endocr J; 2001 Apr; 48(2):249-53. PubMed ID: 11456275
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells.
    Diascro DD; Vogel RL; Johnson TE; Witherup KM; Pitzenberger SM; Rutledge SJ; Prescott DJ; Rodan GA; Schmidt A
    J Bone Miner Res; 1998 Jan; 13(1):96-106. PubMed ID: 9443795
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcription suppression of peroxisome proliferator-activated receptor gamma2 gene expression by tumor necrosis factor alpha via an inhibition of CCAAT/ enhancer-binding protein delta during the early stage of adipocyte differentiation.
    Kudo M; Sugawara A; Uruno A; Takeuchi K; Ito S
    Endocrinology; 2004 Nov; 145(11):4948-56. PubMed ID: 15284209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peroxisome-proliferator-activated receptor gamma suppresses Wnt/beta-catenin signalling during adipogenesis.
    Moldes M; Zuo Y; Morrison RF; Silva D; Park BH; Liu J; Farmer SR
    Biochem J; 2003 Dec; 376(Pt 3):607-13. PubMed ID: 12954078
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endrin inhibits adipocyte differentiation by selectively altering expression pattern of CCAAT/enhancer binding protein-alpha in 3T3-L1 cells.
    Moreno-Aliaga MJ; Matsumura F
    Mol Pharmacol; 1999 Jul; 56(1):91-101. PubMed ID: 10385688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.